SEC Form 4 · accession 0001615774-16-004868
Emmaus Life Sciences, Inc. · EMMA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Michal Votruba
Director
Period of report
Apr 5, 2016
Accepted (ET)
Apr 7, 2016 · 9:12 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000822370
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 5, 2016 | A | 250,000 | $0.00 | A | 250,000 | D |
Table II — derivative securities
No Table II lines on this filing.